JP Morgan Maintains Overweight on IBM, Lowers Price Target to $250

Benzinga Newsdesk www.benzinga.com Negative 93.7%

Neg 93.7% Neu 0% Pos 0%

JP Morgan analyst Brian Essex maintains IBM (NYSE:IBM) with a Overweight and lowers the price target from $291 to $250.

Comments

No comments yet. Be the first!